Previous 10 | Next 10 |
ABCAM PLC: Final results for the year ended 31 December 2022 PR Newswire 15% Reported Revenue Growth & 8% Constant Exchange Rate Revenue Growth: Demand for Abcam In-house Products Continues CAMBRIDGE, England and WALTHAM, Mass. , March 20, 2023 ...
Abcam to Report Full Year Results on Monday, March 20, 2023 PR Newswire CAMBRIDGE, England and WALTHAM, Mass. , March 10, 2023 /PRNewswire/ -- Abcam plc (Nasdaq: ABCM) (" Abcam " or the " Company "), a global leader in the supply of life science resea...
Summary Abcam stock trades at a premium of ~122% to peers at 43x forward earnings. The premium seems unjustified, as growth has come at a cost to equity holders. The reinvestment of post-tax earnings for growth hasn't delivered high rates of return, either. Net-net, rate hold. ...
Summary Abcam develops antibodies and provides them to life science research firms in the U.S., EMEA, and China. Revenue growth is cyclical, with the highest YoY number at around 24% and the lowest at -2%. Net income is on a downward trend, with current net income TTM (trailing 12 m...
Summary NSTG looks primed for a steep correction as the share price has soared since its last earnings report, which was weak on a quarterly basis, but also on guidance. Among the positive catalysts for the company are a partnership with Abcam, top management buying shares, and a recent...
ABCAM PLC: Trading Update PR Newswire CAMBRIDGE, England and WALTHAM, Mass. , Jan. 30, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following prel...
Summary Baillie Gifford’s 13F portfolio value decreased from ~$96.99B to ~$95.96B this quarter. They increased NVIDIA, Shopify, NIO Inc., SEA Ltd., Roblox, DoorDash, and Ginkgo Bioworks while reducing Illumina, Ferrari N.V., Arthur J. Gallagher & Co., Albemarle, Meta Platform...
Summary Vir Biotechnology is a commercial-stage immunology company that bases its activity on infectious disease prevention. The agreement with GSK made it possible to obtain large revenues and profits in 2022. A good pipeline allows us to assume high growth in the coming years. ...
Abcam plc: Update on AIM Delisting PR Newswire CAMBRIDGE, England and WALTHAM, Mass. , Dec. 12, 2022 /PRNewswire/ -- Abcam plc, (AIM: ABC) and (NASDAQ: ABCM) (" Abcam " or the " Company "), a global leader in the supply of life science research t...
ABCAM PLC: Result of General Meeting - Shareholders approve AIM Delisting PR Newswire CAMBRIDGE, England and WALTHAM, Mass. , Nov. 11, 2022 /PRNewswire/ -- Abcam plc (AIM: ABCM) (ABC: ABCM) (Nasdaq: ABCM) ("Abcam" or the "Company"), a global leader in...
News, Short Squeeze, Breakout and More Instantly...
Danaher Completes Acquisition of Abcam PR Newswire WASHINGTON , Dec. 6, 2023 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The acquisition of Abcam for $24.0...
Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition by Danaher Corporation (NYSE: DHR) ...
2023-11-19 06:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...